REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 144 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $130,000 | +217.1% | 5,241 | +94.2% | 0.01% | +166.7% |
Q1 2020 | $41,000 | +57.7% | 2,699 | +66.3% | 0.00% | +50.0% |
Q4 2019 | $26,000 | +85.7% | 1,623 | +55.6% | 0.00% | +100.0% |
Q3 2019 | $14,000 | +16.7% | 1,043 | +69.9% | 0.00% | 0.0% |
Q4 2018 | $12,000 | +140.0% | 614 | +383.5% | 0.00% | – |
Q4 2017 | $5,000 | -54.5% | 127 | -74.9% | 0.00% | -100.0% |
Q1 2017 | $11,000 | -31.2% | 505 | -33.5% | 0.00% | -50.0% |
Q4 2016 | $16,000 | – | 759 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |